1 week Ago By Defense World Staff
Bank of Montreal Can boosted its stake in shares of Invesco Pharmaceuticals ETF ( NYSEARCA:PJP – Free Report ) by 48.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,044 shares of the company’s stock after purchasing an additional 342 shares during the period.
Bank of Montreal Can’s holdings in Invesco Pharmaceuticals ETF were worth $86,000 at the end of the most recent reporting period. A number of other large investors have also added to or reduced their stakes in the stock. MGB Wealth Management LLC boosted its stake in shares of Invesco Pharmaceuticals ETF by 11.
9% in the 4th quarter. MGB Wealth Management LLC now owns 21,976 shares of the company’s stock worth $1,815,000 after buying an additional 2,345 shares during the last quarter. Joseph Group Capital Management grew its stake in shares of Invesco Pharmaceuticals ETF by 15.
4% during the 4th quarter. Joseph Group Capital Management now owns 17,397 shares of the company’s stock valued at $1,437,000 after purchasing an additional 2,317 shares during the period. Jane Street Group LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter valued at about $1,163,000.
Raymond James Financial Inc. bought a new position in shares of Invesco Pharmaceuticals ETF in the 4th quarter worth approximately $943,000. Finally, Commonwealth Retirement Investments LLC purchased a new position in shares of Invesco Pharmaceuticals ETF in the fourth quarter worth approximately $401,000.
Invesco Pharmaceuticals ETF Trading Up 0.6 % Shares of NYSEARCA PJP opened at $79.85 on Friday.
Invesco Pharmaceuticals ETF has a 12-month low of $72.25 and a 12-month high of $89.87.
The firm has a market capitalization of $240.35 million, a price-to-earnings ratio of 19.60 and a beta of 0.
56. The firm has a 50 day moving average of $82.51 and a 200 day moving average of $84.
46. Invesco Pharmaceuticals ETF Company Profile PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index).
The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Further Reading Five stocks we like better than Invesco Pharmaceuticals ETF 2 Fintech Stocks to Buy Now and 1 to Avoid Markets Think Robinhood Earnings Could Send the Stock Up Low PE Growth Stocks: Unlocking Investment Opportunities Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Special Purpose Acquisition Company (SPAC) What You Need to Know AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF ( NYSEARCA:PJP – Free Report ).
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter ..
